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ABSTRACT
THE ROLE OF THE TRANSCRIPTION FACTOR ATF4 IN TUMOR
PROGRESSION UNDER NUTRIENT DEPRIVATION AND HYPOXIA
Jiangbin Ye
Supervisor: Constantinos Koumenis
The transcription factor ATF4 regulates the expression of mRNAs involved in
amino acid metabolism, redox homeostasis and ER stress responses. Its
overexpression in human solid tumors suggests an important role in tumor biology.
Here we report that inhibition of ATF4 expression blocks proliferation and survival of
transformed cells, despite an initial activation of cytoprotective macroautophagy.
Knockdown of ATF4 significantly reduced the levels of asparagine synthetase
(ASNS). Overexpression of ASNS or supplementation of asparagine in trans, reverses
the proliferation block and increases survival in ATF4 knockdown cells. Both amino
acid and glucose deprivation, stresses found in solid tumors, activate the upstream
eIF2α kinase GCN2 to upregulate ATF4 target genes involved in amino acid synthesis
and transport. Levels of total GCN2, phospho-GCN2 and phospho-eIF2α were
upregulated in samples of human and mouse tumors compared to normal tissues and
abrogation of ATF4 or GCN2 expression significantly inhibited tumor growth in vivo.
ATF4 also contributes to the hypoxic resistance of tumor cells. We conclude that the
GCN2-eIF2α-ATF4 pathway is critical for maintaining metabolic homeostasis in
tumor cells, making it a novel and attractive target for anti-tumor therapy.
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Chapter I: General Introduction

The tumor microenvironment consists of stromal cells, nutrients, growth
factors, extracellular matrix, and blood vessels that surround and nourish tumor cells
(Yuan and Glazer, 1998). Through interactions between tumor cells, fibroblasts,
infiltrating immune cells, extracellular matrix and cytokines, tumor cells can alter the
microenvironment, and conversely, the microenvironment can also influence tumor
progression. (Gonda et al., 2009; Whiteside, 2008). Additionally, fluctuations in the
concentrations of oxygen and nutrients (e.g. glucose and amino acids) can impact on
tumor cell survival, proliferation, angiogenesis and migration. Because of their fast
proliferation, high metabolism rate and abnormal tumor vasculature, tumor cells are
often exposed to stresses such as hypoxia, low glucose and amino acid starvation.
The work herein describes studies on how the Activating Transcription Factor 4
(ATF4) contributes to tumor cell resistance to these stresses.

Hypoxia promotes tumor progression
Tumor hypoxia constitutes a dynamic feature of tumor microenvironment that
contributes to tumor progression, which develops due to several factors, including: (a)
uncontrolled cellular proliferation that results in tumors outgrowing their
blood/oxygen supply creating chronic or diffusion-limited hypoxia; (b) an immature
and structurally abnormal newly formed tumor vasculature that can be leaky and
cause acute or perfusion-limited hypoxia (Brown, 2000; Harris, 2002); (c) increased
1

metabolic activity of tumor cells compared to normal cells (Jones and Thompson,
2009). Clinically, tumor hypoxia is a significant obstacle to therapy. Hypoxic tumor
cells are more resistant to ionizing radiation compared to more normoxic tumor tissue
because of the incomplete fixation of DNA damage (Hockel et al., 1996b; Nordsmark
et al., 1996). Because of slow proliferation rates, limited diffusion and tissue acidosis,
hypoxic cells are also less sensitive to chemotherapeutic drugs (Sutherland et al., 1979;
Teicher et al., 1990; Wike-Hooley et al., 1984). Hypoxia also contributes to malignant
progression. Several clinical studies and experimental mouse models showed that
tumor hypoxia is associated with increased metastatic potential (Brizel et al., 1996;
Cairns and Hill, 2004; Hockel et al., 1996a), and more recently, attenuation of cellular
senescence (Welford et al., 2006). Hypoxia selects for colonial expansion of tumor
cells with mutated p53 (Graeber et al., 1996) and increases genome instability which
contributes to a more aggressive phenotype (Reynolds et al., 1996). Moreover,
hypoxia promotes tumor angiogenesis primarily though hypoxia inducible factor (HIF)
induced vascular endothelial growth factor (VEGF) (Hlatky et al., 1994; Maxwell et
al., 1997). Therefore, it is important to elucidate the mechanisms by which hypoxia
affects tumor physiology at the cellular and molecular levels, which can lead to the
development of novel therapeutic methods targeting hypoxic tumors that will
ultimately improve therapeutic outcome.

Molecular mechanisms of cellular adaptation to hypoxia.
The hypoxia-inducible factors 1 and 2 (HIF-1 and HIF-2) play a major role in
2

cellular and tumor adaptation to hypoxia by regulating the expression of over 200
genes involved in angiogenesis, glycolysis, apoptosis, metastasis, proliferation and
differentiation (Gordan and Simon, 2007). In addition to HIF-dependent pathways,
adaptation to hypoxia inevitably involves downregulation of macromolecular
synthesis which is a major source of energy consumption in tumor cells, thereby
coupling low oxygen availability and reduced oxidative phosphorylation to energy
demands (Koumenis and Wouters, 2006). Since the process of mRNA translation is an
energy-consuming process, reducing the rate of translation is necessary for cell
survival under low oxygen levels. This inhibition of translation is largely mediated
though the inhibition of eukaryotic initiation factor 2α (eIF2α) and eukaryotic
initiation factor 4E (eIF4E), and to a smaller extent, inhibition of elongation factor
eEF-2 (Arsham et al., 2003; Koumenis et al., 2002; Liu et al., 2006). Previous studies
from our lab and other labs have showed that PERK-dependent eIF2α
phosphorylation under hypoxia is necessary for tumor cells survival (Bi et al., 2005).

The PERK/ eIF2α/ATF4 module of the UPR (unfolded protein response) is
activated by hypoxia induced ER stress.
There are three ER stress signal transducers located on the ER membrane:
IRE1, ATF6 and PERK (Figure I-1). The ER lumenal domains of these proteins are
bound by ER chaperone BiP/GRP78 under unstressed conditions so that the
cytoplasmic kinase domain is inactive. Upon ER stress, such as when
unfolded/misfolded proteins accumulate in the ER, these transmembrane proteins are
3

activated (Malhotra and Kaufman, 2007) presumably by release from BiP/GRP78
(Bertolotti et al., 2000). Activation of IRE1 leads to Xbp1 mRNA splicing, allowing
more efficient synthesis of XBP1 protein, a transcription factor that translocates to the
nucleus and activates gene expression; ATF6 released from BiP transits to the Golgi
body for cleavage, releasing an activated transcription factor to regulate gene
expression in the nucleus; BiP releases the lumenal domain of PERK, allows PERK
dimerization and autophosphorylation which leads to PERK activation (Ron and
Walter, 2007) (Figure I-1). Activated PERK directly phosphorylates eIF2α at Ser51,
leading to downregulation of global translation (Shi et al., 1998). However, under
certain conditions such as virus infection, PERK activation may not cause translation
inhibition (Isler et al., 2005). This PERK/ eIF2α/ATF4 pathway was shown to be
activated by prolonged hypoxia and anoxia (Bi et al., 2005; Koritzinsky et al., 2006;
Koumenis et al., 2002; Liu et al., 2006). At the same time, phosphorylation of eIF2α
promotes the translational activation of ATF4 (see below).
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Figure I-1. The Unfolded Protein Response.
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Integrated stress responses and the translational regulation of ATF4
Gene expression in eukaryotic cells is regulated at multiple levels. Compared
to transcriptional regulation, translational regulation is capable of adjusting protein
levels more rapidly and directly, allowing cells to quickly respond to environmental
changes and maintain intracellular homeostasis. Under a variety of stresses, including
nutrient deprivation, endoplasmic reticulum (ER) stress, hypoxia, virus infection, etc.,
the eukaryotic translational initiation factor eIF2α is phosphorylated at Ser51. In
mammalian cells, four eIF2α kinases have been identified. HRI (heme regulated
initiation factor 2 alpha kinase, EIF2AK1) is activated by heme deprivation; PKR
(interferon-inducible RNA-dependent protein kinase, EIF2AK2) is activated by
double-stranded RNA; PERK (PKR-like endoplasmic reticulum kinase, EIF2AK3) is
activated by unfolded proteins in the ER; GCN2 (general control non-depressible
kinase 2, EIF2AK4) is activated by uncharged tRNAs. Activation of all these kinases
leads to eIF2α phosphorylation, therefore the term ‘integrated stress responses’ is
used to describe this pathway (Figure I-2). eIF2α phosphorylation blocks the
eIF2B-dependent recycling of eIF2-GDP to eIF2-GTP, causing global translation
inhibition. Decreased translation helps cells to conserve nutrients and energy, slowing
down the cell cycle (Koumenis and Wouters, 2006; Ron and Walter, 2007).
Although global translation is suppressed upon eIF2α phosphorylation,
paradoxically, a group of stress-responsive mRNAs that include ATF4 are translated
more efficiently when eIF2α is phosphorylated (Harding et al., 2000a).

This

translational regulation model was first characterized in the yeast homolog GCN4 of
6

ATF4 and was later found to also exist in mammalian cells (Harding et al., 2000;
Hinnebusch, 1984; Mueller and Hinnebusch, 1986; Vattem and Wek, 2004). ATF4
belongs to the activating transcription factor/cAMP responsive element binding
protein (ATF/CREB) family which has a consensus binding site (cAMP responsive
element, CRE) defined as TGACGT(C/A)(G/A) (Ameri and Harris, 2008; Hai and
Hartman, 2001). Although transcriptional regulation of ATF4 has also been reported
(Estes et al., 1995); (Kokame et al., 1996; Sato et al., 1998); (Siu et al., 2002), it is the
translational regulation of ATF4 that has been more extensively studied.

The mammalian ATF4 mRNA has two upstream open reading frames (uORFs)
located in the 5’UTR of the mRNA. uORF1 promotes ribosome scanning and
reinitiating at uORF2 when abundant eIF2-GTP is available. Because uORF2 overlaps
with the actual ATF4 ORF, the translation of uORF2 produces a non-functional
product which causes ribosome release from the ATF4 mRNA, thereby repressing
ATF4 translation under unstressed conditions (Harding et al., 2000; Lu et al., 2004;
Vattem and Wek, 2004). When cells are exposed to stresses, eIF2α phosphorylation
reduces eIF2-GTP levels so that the translation reinitiation at uORF2 is inhibited,
allowing the ribosome small subunit to bypass uORF2 and start translation at the true
ATF4 ORF in order to increase ATF4 protein level (Figure I-3). Two ATF4 targets
ATF5 and GADD34 are translationally regulated in a similar manner (Lee et al., 2009;
Watatani et al., 2008; Zhou et al., 2008).
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Figure I-2. The Integrated Stress Response. Four eIF2α kinases have been
discovered in mammalian cells: HRI is activated by heme deprivation; PKR is
activated by double-stranded RNA; PERK is activated by ER stress; GCN2 is
activated by uncharged tRNA. Activation of these kinases causes eIF2α
phosphorylation at Ser51 and activates integrated stress response pathway. eIF2α
phosphorylation blocks the eIF2B-dependent recycling of eIF2-GDP to eIF2-GTP,
causing global translation inhibition. Paradoxically,

phosphorylated eIF2α also

results in upregulation of a group of stress-responsive genes including ATF4 and some
of ATF4 targets including ATF5 and GADD34.
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ATF4 and its target genes are induced by hypoxia.
Although it was reported that rat embryonic fibroblasts exposed to anoxia
show overexpression of ATF4 mRNA (Estes et al., 1995), studies in other systems
(mouse and human cell lines) have shown that hypoxia/anoxia does not cause
substantial upregulation of ATF4 mRNA (Ameri et al., 2004; Bi et al., 2005; Blais et
al., 2004). The induction of ATF4 protein levels under hypoxia is not dependent on
HIF-1, as it occurs in HIF-1α knock-down cells (Ameri et al., 2004; Blais et al., 2004;
Koritzinsky et al., 2006). ATF4 was found to be translationally upregulated under
hypoxia in several tumor cell lines and ATF4 protein levels were significantly higher
in tumor samples compared to corresponding normal human tissue (Ameri et al., 2004;
Bi et al., 2005; Blais et al., 2004). Moreover, the expression of ATF4 was found to
overlap with hypoxic regions in human tumor samples of patients with cervical
carcinoma who had received the hypoxia-sensitive dye pimonidazole (Ameri et al.,
2004; Bi et al., 2005). Our group also reported that ATF4-/- MEFs are more sensitive
to prolonged hypoxia-induced apoptosis compared to ATF4+/+ MEFs(Bi et al., 2005).
Together, these data suggest that increased ATF4 levels may play an important role in
tumorigenesis. The functions of some of the ATF4 targets induced by hypoxia are
discussed below.
CHOP/GADD153: C/EBP homologous protein (CHOP) is a basic leucine zipper
(bZIP) transcription factor implicated in ER stress-induced apoptosis (Zinszner et al.,
1998). It was shown to enhance apoptosis via repressing expression of anti-apoptotic
Bcl-2 and the antioxidant GSH (McCullough et al., 2001) or by inducing death
10

receptor 5 (DR5) in response to cyclooxygenase-2 (COX-2) inhibitors (He et al.,
2007). CHOP is upregulated by ATF4 in response to many cellular stress signals such
as arsenite (Fawcett et al., 1999), amino acid deprivation (Averous et al., 2004) and
hypoxia. However, the role of CHOP in hypoxic tumor cell survival has not been
carefully examined yet.
TRB3/SKIP3: TRB3 is the human ortholog of the Drosophila tribbles gene product.
TRB3 is induced by hypoxia in tumors in an ATF4-dependent manner (Bowers et al.,
2003), though it was later found that induction of TRB3 by ER stress depends on both
ATF4 and CHOP (Ohoka et al., 2005; Ord and Ord, 2005). The data so far point
towards a model in which TRB3 creates a negative feedback for ATF4/CHOP
induction by directly binding to both ATF4 and CHOP to inhibit their transcriptional
activities (Ohoka et al., 2005; Ord and Ord, 2003).
GADD34: GADD34 is a protein that interacts with the catalytic subunit of protein
phosphatase 1 (PP1) to promote dephosphorylation of p-eIF2α thereby allowing
translation recovery from ER stresses (Novoa et al., 2001). GADD34 has a consensus
ATF/CREB binding site in its promoter and its induction by ER stress and hypoxia is
ATF4 dependent (Blais et al., 2004; Ma and Hendershot, 2003). Therefore, induction
of GADD34 creates not only a negative feedback loop in regulating ATF4, but also
helps recovery of translation when stressed conditions are alleviated.
ATF3: ATF3 is another ATF family member induced by ATF4 under ER stress and
anoxia, and it contributes to CHOP and GADD34 induction in response to stress
(Ameri et al., 2007; Jiang et al., 2004). Several reports have suggested that ATF3 can
11

be a ‘double-edged sword’ in tumor development. On one hand, it stabilizes p53 upon
genotoxic stress to inhibit cellular transformation (Yan and Boyd, 2006); on the other
hand, it is also known to promote cellular proliferation in response to serum
stimulation (Tamura et al., 2005). A recent study demonstrated that ATF3 promotes
apoptosis in untransformed mammary epithelial cells but enhances migration in
malignant cells via induction of pro-metastatic genes (Yin et al., 2007).

ATF4 has important functions during development and tumor resistance to
genotoxic stress
Expression of ATF4 mRNA has been detected in various tissues including
bone marrow, kidney, lung, heart, skeletal muscle, brain, spleen and pancreas, etc.
ATF4 appears to play multiple roles during development: ATF4 knockout mice have
abnormal lens formation, growth retardation, anemia and delayed bone development
(Masuoka and Townes, 2002; Tanaka et al., 1998; Yang et al., 2004). Interestingly,
ATF4 also has key functions in neural system activity and development. In addition to
affecting long-term synaptic plasticity and memory formation storage (Chen et al.,
2003; Costa-Mattioli et al., 2005; Costa-Mattioli et al., 2007), it has been proposed
that the induction of ATF4 upon mental stress may also help reduce emotional
reactivity and enhance depression-like behavior (Green et al., 2008). It is postulated
that the interaction between ATF4 and γ-aminobutyric acid type B receptor may
account for the functions of ATF4 in these neuron activities (Vernon et al., 2001;
White et al., 2000).
12

In terms of tumor relevance, dysregulation of ATF4 expression has been
implicated in induction of chemo-radioresistance. ATF4 mRNA levels correlate with
tumor cell resistance to DNA-interacting drugs such as cisplatin, and overexpression
of ATF4 reduces cell sensitivity to cisplatin (Levenson et al., 2000; Tanabe et al.,
2003). Moreover, recent work suggests that the circadian regulator protein Clock
binds to the E-box in the ATF4 promoter and transcriptionally upregulates ATF4 in
response to cisplatin, which induces enzymes involved in glutathione metabolism and
contributes to chemoresistance (Igarashi et al., 2007).

Tumor cells have high consumption rate of glucose and glutamine
In addition to hypoxia, tumor cells undergo nutrient starvation because they
have much higher demands on nutrients compared to normal cells. It has been shown
that activation of oncogenes is responsible for high metabolism rate of small
molecular nutrients (DeBerardinis et al., 2008). For instance, many tumor cells have
high rate of glucose uptake and glycolysis (Warburg, 1956), defined as ‘Warburg
effect’. Clinically, the high glucose consumption rate of cancer cells is exploited by
the positron-emission tomography (PET) imaging technique which employs
18

F-2-deoxyglucose, a glucose analogue that can be absorbed but not metabolized by

tissues, to measure glucose absorption rate. In addition to glucose, tumor cell also rely
on high glutamine to produce energy, NADPH, as well as carbon source for
non-essential amino acid and lipids synthesis (Chen et al., 1993; Coles and Johnstone,
1962; DeBerardinis et al., 2007). The oncogene c-myc transcriptionally upregulates
13

glutamine transporters such as ASCT2 and also represses microRNA miR-23a/b,
leading to increased expression of their target gene, mitochondrial glutaminase, which
upregulates glutamine metabolism (Gao et al., 2009; Wise et al., 2008).

The eIF2α kinase GCN2
Unlike PERK, which is activated by ER stress, GCN2 is a high molecular
weight protein kinase activated by uncharged tRNA (Ramirez et al., 1992; Wek et al.,
1990; Wek et al., 1995). GCN2 has a domain homologous to histidyl-tRNA
synthetases (HisRSs) located next to the kinase catalytic moiety (Wek et al., 1989).
Uncharged tRNA binds to synthetase-related domain of GCN2 (Dong et al., 2000;
Wek et al., 1995), activiting the GCN2 kinase. Activated GCN2 phosphorylates eIF2α
to translationally upregulate ATF4, which in turn increases amino acid biosynthetic
and transport pathways (Harding et al., 2000; Harding et al., 2003).
GCN2 knockout mice are viable and fertile and display no gross phenotypic
abnormalities under standard feeding conditions. However, if the diet lacks a single
amino acid, there is a remarkable increase of prenatal death rate and liver abnormality
(Anthony et al., 2004; Zhang et al., 2002). Other than maintaining amino acid
homeostasis, GCN2 also regulates synaptic plasticity and memory (Costa-Mattioli et
al., 2005)，feeding behavior (Hao et al., 2005; Maurin et al., 2005), as well as lipid
metabolism (Guo and Cavener, 2007). GCN2 is also activated by UV radiation and
mediates NF-κB signaling (Deng et al., 2002; Jiang and Wek, 2005).

14

Autophagy
A critical stress response process which is activated by nutrient deprivation is
autophagy. Autophagy is a lysosomal-dependent intracellular degradation pathway
activated in response to nutrient starvation ， organelle damage or intracellular
microorganisms (Mizushima, 2007). Most of current evidence suggests that inhibition
of mTOR activity under amino acid starvation is the initiating signal for autophagy
induction in eukaryotic cells (Diaz-Troya et al., 2008). In yeast, under amino acid
starvation,

autophagy

induction

depends

on

activated

GCN2

and

eIF2α

phosphorylation (Talloczy et al., 2002). The process of autophagy includes several
steps: (a) Cellular material (proteins/damaged organelles/microorganism) is
sequestrated by phagophore or isolation membrane to form a double-membrane
autophagosome; (b) Autophagosomes are merged with lysosomes and the cargoes are
digested by lysosomal hydrolases together with the inner membrane of the
autophagosome; (c) Monomers from degraded macromolecules (such as amino acids)
can then be reused by the cell (Mizushima, 2007). Autophagy may promote cell
survival in at least two ways: (a) Degrade unnecessary macromolecules and cellular
components to release monomers for satisfying the minimum requirements for
maintaining essential functions of the cell; (b) Eliminate damaged organelles and
harmful inclusions, hence teleologically, in the short term it is considered a protective
stress response (Degenhardt et al., 2006).

However, prolonged induction of

autophagy may also lead to irreversible cell death (autophagic cell death) in
apoptosis-resistance cells (Bursch, 2001; Shimizu et al., 2004).
15

Project aims
Tumor cells have to adjust multiple metabolic and stress response pathways so
that they can adapt to and survive through the unfavorable tumor microenvironment.
Our group has been interested in the regulation of these pro-survival pathways and
how to target these pathways for tumor therapy. Our lab’s previous findings
demonstrated that PERK activation and eIF2α phosphorylation are necessary for
tumor cell survival under hypoxia and promote tumor growth. Additionally, the PERK
downstream target ATF4 was found to be overexpressed in tumor tissues. In this study,
we set out to investigate whether ATF4 contributes to hypoxic resistance of tumor
cells and how hypoxia regulates ATF4 target genes expression. In the process of these
studies, we discovered that in addition to its role in hypoxia resistance, ATF4 also
contributes to intracellular amino acid homeostasis. Since transformed cells in the
context of solid tumors are usually exposed to metabolic stresses, and GCN2 is a key
molecular sensor responding to nutrient deprivation, we investigated whether the
GCN2-ATF4 pathway regulates tumor cell amino acid metabolism and tumor
progression. We discovered that activation of GCN2 is critical for tumor cell survival
under amino acid and glucose deprivation; and moreover, inhibition of GCN2-ATF4
pathway reduces tumor xenograft growth in vivo.
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Chapter II: The role of the transcription factor ATF4 in
regulating tumor cell proliferation and survival by
activating asparagine biosynthesis

This Chapter contributes to part of a manuscript submitted to EMBO J. (in revision)

Introduction
Previous studies in mouse embryonic fibroblasts (MEFs) demonstrated that
ATF4 is a critical regulator of genes involved in redox balance and maintenance of
amino acid homeostasis. Consequently, ATF4-/- MEFs require non-essential amino
acids to survive and proliferate (Harding et al., 2003). So far, many genes involved in
amino acid metabolism have been identified as ATF4 targets, including asparagine
synthetase (ASNS) (Siu et al., 2002), solute carrier family 7, member 5 (Slc7a5),
asparaginyl-tRNA synthetase (NARS) etc. (Harding et al., 2003). Though ATF4
overexpression in tumor tissues has been reported (Ameri et al., 2004; Bi et al., 2005),
the role of ATF4 in regulating tumor cell amino acid metabolism or the precise
functions of ATF4 in tumor cell survival and proliferation have not been elucidated
yet.
Asparagine synthetase (ASNS) is an enzyme that catalyzes the ATP- and
glutamine-dependent conversion of L-aspartate to L-asparagine (Asn), a non-essential
amino acid that is required for protein synthesis and cell growth (Richards, Shuster
1998). ASNS was first indentified that in temperature-sensitive hamster cell line BHK
ts11, a point mutation on ASNS gene leads to the production of an inactive enzyme at
17

non-permissive temperature, causing G1 phase cell cycle arrest (Gong and Basilico,
1990). The mRNA levels of ASNS are strongly induced by amino acid starvation
(Gong et al., 1991) since the ASNS promoter has amino acid response element
(AARE) and nutrient sensing response elements (NRSEs) that ATF4 binds to
(Barbosa-Tessmann et al., 2000; Guerrini et al., 1993; Siu et al., 2002).
In this study, we report that the knockdown of ATF4 reduces the survival and
proliferation of two tumor cell lines (HT1080 and DLD1) in vitro. We show that ATF4
is necessary for ASNS expression that maintains asparagine production, which is
crucial for cell survival and proliferation. Insufficient asparagine production induces
G1 phase cell cycle arrest, apoptosis and autophagy in tumor cells. The induction of
autophagy facilitates tumor cells to survive under asparagine deficiency.

Since

ASNS needs glutamine to synthesize asparagine, ATF4 knockdown cells are sensitive
to glutamine deprivation. In vivo xenograft experiments demonstrated that ATF4
inhibition reduces tumor growth, suggesting ATF4 can be targeted for tumor therapy.
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Results
Generation of stable ATF4 knockdown cell lines
To investigate the role of ATF4 in tumor cell proliferation and survival,
plasmids expressing ATF4 specific shRNA (pSM2-shATF4) or non-targeting shRNA
(pLKO-shNT) were transfected into HT1080 (human fibrosarcoma, p53 wild-type) or
DLD1 (human colorectal adenocarcinoma, p53-mutant) cells. Two established
HT1080 shATF4 clones (shATF4.cl3 and shATF4.cl4) and one DLD1 shATF4 clone
showed between 60-70% reduction of ATF4 mRNA levels compared to corresponding
shNT clones (Figure II-1A). Since the basal ATF4 protein levels are low in unstressed
cells, we treated cells with the ER stress-inducing agent thapsigargin to upregulate
ATF4. Consistent with mRNA levels, both HT1080 and DLD1 shATF4 clones showed
no ATF4 induction after treatment with thapsigargin (Figure II-1B).

ATF4 expression is required for survival of tumor cells in the absence of
non-essential amino acid supplementation.
It was previously reported that ATF4-/- MEFs require the presence of
non-essential amino acids (NEAA) and antioxidant such as β-mercaptoethanol (β-ME)
to survive (Harding et al., 2003) (Figure II-2A). Similar to SV40-immortalized
ATF4-/- MEFs, tumor cells expressing ATF4 shRNA demonstrated significantly
reduced survival in the absence of NEAA (Figure II-2B). In contrast, cell survival of
HT1080.shATF4 was not affected by adding β-ME at concentrations from 25µM to
0.2mM (data not shown).
19

A.
HT1080

*

1

*

1. 2

DLD1

*

1

ATF4 mRNA levels

ATF4 mRNA levels

1.2

0.8
0.6
0.4
0.2

0. 6
0. 4
0. 2
0

shATF4-cl4

shNT

shATF4-cl3

0

0. 8

shNT

shATF4cl3

B.
Tg

sh A
TF4

cl4

cl3

shN

cl4

cl3

shN
T

DMSO

T

DMSO
s hN
T

DLD1
Tg
s hN
T
sh A
TF4

HT1080

ATF4
Lamin A/C

Figure II-1. Generating stable shATF4 cell lines. (A) Real time RT-PCR analysis
for ATF4 mRNA levels in HT1080 and DLD-1 clones expressing none-targeting
shRNA (shNT) or shRNA targeting human ATF4 (shATF4). mRNA levels were
normalized against 18s rRNA internal control and are reported as a fraction compared
to levels in shNT control cells. PCR reactions were done in triplicate. (Data represent
mean ± SEM, n=3, *p<0.05.) (B) ATF4 protein levels from the nuclear fractions of
thapsigargin-treated (Tg, 1μM, 4h) or DMSO-treated cells. Lamin A/C was used as a
loading control.
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Figure II-2. Knock-down of ATF4 inhibits tumor cell survival. (A) ATF4+/+ and
ATF4-/- MEFs were incubated in DMEM with ingredients indicated for 48h. Cell
survival was measured using MTT assay. (B) Survival of HT1080 and DLD1 cells
cultured in the presence or absence of NEAA (100μM) measured by MTT assay 48h
after plating (Data represent mean±SEM, n = 3, *p < 0.05.). Cell survival was
normalized to control (shNT cells without NEAA).
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Knockdown of ATF4 induces G1 phase cell cycle arrest and proliferation arrest.
Reduced cell survival of HT1080.shATF4 cells could result from decreased
cell proliferation and/or increased cell death. By performing fluorescent EdU
incorporation in exponentially growing cells, we found that that shATF4 cells showed
a 35% reduction in cell proliferation compared to shNT cells (Figure II-3A). Adding
NEAA to the medium led to full recovery of cell proliferation (Figure II-3B). Flow
cytometric analysis also demonstrated that shATF4 cells had an increased G1
population compared to shNT cells (Figure II-3C), indicating that ATF4 knockdown
causes G1/S arrest in tumor cells. Addition of NEAA partially reversed the G1 arrest.
These data suggest that ATF4 deficiency induces amino acid starvation which causes
G1/S cell cycle arrest and reduced proliferation.
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Figure II-3. Knockdown of ATF4 inhibits cell proliferation. (A) Cell proliferation
assay. HT1080 cells were plated in DMEM with/without NEAA for 24h.

Upper

panel: Fluorescent staining for nuclei (Hoechst, blue) and proliferating cells with EdU
(red). Lower panel: Three randomly selected photographs were selected and numbers
of EdU positive and total nuclei were counted. % proliferation index was calculated
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by dividing the number of proliferating nuclei by the total number of nuclei. (Data
represent mean ± SEM, n=3, *p<0.05.) (B) Cell proliferation of HT1080 and DLD1
cells measured using flow cytometry EdU assay. EdU-: EdU negative cells, arrested
population; EdU+: EdU positive cells, proliferating population. Cells were incubated
in DMEM with amino acids for 24h. (C) Cell cycle was analyzed by propidium iodide
(PI) staining using CellQuest (Becton Dickinson). Cells were incubated in DMEM
with amino acids for 24h.
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Knockdown of ATF4 in transformed cells induces apoptosis.

When the HT1080 ATF4 knockdown cells were cultured in the absence of
NEAA, morphological features of apoptosis such as blebbing and spiking were
observed, which were diminished by the addition of NEAA (Figure II-4A). shATF4
cells also had higher levels of cleaved-PARP, an apoptosis marker, which was
similarly reduced in the presence of NEAA (Figure II-4B). To further analyze the
levels of apoptosis in shATF4 cells cultured without NEAA, we measured caspase 3/7
activities. shATF4 cells exhibited over a 13-fold increase in basal caspase 3/7 activity
compared to shNT cells; similarly, supplementation with NEAA significantly reduced
the caspase activities (Figure II-4C).
To exclude the possibility that the defects of shATF4 cells were due to
off-target effects of the shRNA or selection-induced mutations, we overexpressed
full-length mouse ATF4 that was not targeted by the shRNA against human ATF4
using an adenoviral vector. Overexpression of mATF4 significantly increased cell
survival and blocked the apoptotic phenotype of shATF4 cells (Figures II-4D, E).
These findings further support a pro-survival role of ATF4 in these tumor cells.
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Figure II-4. Knock-down of ATF4 induces apoptosis in tumor cells.

(A)

Phase-contrast images of HT1080 shNT and shATF4 cells growing in DMEM with or
without NEAA for 24h. Images shown were taken at 400 × magnification. (B)
Immunoblot for cleaved-PARP in HT1080 shNT and shATF4 cells. β-actin was used
as a loading control. HT1080 cells were incubated in DMEM with/without NEAA for
24h. (C) Caspase 3/7 activities normalized to total number of cells. HT1080 cells
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were incubated in DMEM with/without NEAA for 24h. (Data represent mean ±
SEM, n=3, *p<0.05.) (D) Phase-contrast images of HT1080 shNT and shATF4 cells
infected with the control (Av-Cre) or adenovirus expressing mouse ATF4 (AV-mATF4)
indicated at 400× magnification. Following infection, cells were incubated in DMEM
without NEAA. Images were taken 24h after infection. (E) Relative cell survival in
infected cells using an MTT assay (top panel). Equal numbers of cells were plated in
DMEM without NEAA 24h after infection. MTT assay was performed after 48h.
(Data represent mean ± SEM, n=3, *p<0.05.) Cells infected under same condition
were also collected at 24h after infection for ATF4 immunoblot (bottom panel).
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Knockdown of ATF4 induces a pro-survival autophagic response

Autophagy is a lysosomal-dependent intracellular degradation process that is
activated by several stresses, primarily by nutrient starvation. Since ATF4 was
reported to regulate genes involved in amino acid biosynthesis and transport (Harding
et al., 2003), we hypothesized that autophagy might be induced in the
HT1080.shATF4 cells as an initial pro-survival response to amino acid deprivation.
This hypothesis was supported by the fact that in the absence of NEAA, shATF4 cells
had a smaller size compared to shNT cells and cytoplasmic vacuoles (a sign of
autophagosome formation) were observed (data not shown). shATF4 cells had
elevated levels of the autophagy marker LC-3II compared to shNT cells (Figure II-5A)
which were reduced to control levels by adding NEAA, indicating that autophagy was
induced by amino acid deprivation.
Under electron microscopy, the HT1080.shNT cells exhibited typical
fibroblast morphology with intact ER and mitochondria, while the shATF4 cells were
smaller, rounded and contained double-membrane autophagosomes, further
confirming extensive induction of autophagy in shATF4 cells (Figure II-5B, arrows
pointing to autophagosomes). Similar to LC-3 processing, addition of NEAA reversed
the autophagic phenotype. To test whether the autophagy induced in shATF4 cells was
a cytoprotective stress response, a siRNA targeting Atg7 (an E1-like ubiquitin
conjugating enzyme required for autophagosome maturation) was employed to inhibit
autophagy. When Atg7 levels were reduced, the shATF4 cells showed increased
apoptosis compared to shNT cells (Figure II-5C, D). These results indicate that the
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autophagy induced by loss of ATF4 in the HT1080 cells promotes survival and that
the combination of losing ATF4 and the inhibition of autophagy results in a
cooperative enhancement of cell death.
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Figure II-5. Knock-down of ATF4 induces protective autophagy in tumor cells.
(A) Immunoblot for the autophagy marker LC-3II from whole cell lysates in HT1080

shNT and shATF4 cells incubated in DMEM with/without NEAA for 24h. β-actin was
used as a loading control. (B) Electron microscopy imaging. Arrows point to double
membrane-containing autophagosomes. HT1080 cells were incubated in DMEM
with/without NEAA for 24h. (C) HT1080 cells were transfected with 100nM
non-targeting siRNA (siNT) or siRNA targeting Atg7 (siAtg7). Atg7 and
cleaved-PARP levels were analyzed by immunoblotting 24h after transfection.
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α-tubulin was used as a loading control. (D) HT1080 cells were transfected with

100nM non-targeting siRNA (siNT) or siRNA targeting ATG7 (siATG7). After 72h,
cell survival of HT1080 and DLD1 cells was measured by MTT assay. Experiment
was done in triplicate. (Data represent mean ± SEM, *p<0.05.)
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Addition of Asn in trans or expression of ASNS, rescues the survival of shATF4
cells.

The mixture of NEAAs utilized in the experiments described above was
comprised of seven amino acids: Ala, Asp, Asn, Glu, Gly, Pro and Ser. Each amino
acid was present at a final concentration of 100µM in DMEM. To determine which
amino acid(s) was/were responsible for mediating the pro-survival effects of ATF4,
individual amino acids were added into DMEM at a 100µΜ final concentration in
cultured shATF4 cells. The results indicated that Asn on its own, but not any other
individual amino acid, could rescue the survival of shATF4 cells (Figure I-6A). An
even more substantial pro-survival effect of Asn was observed in a long-term
clonogenic survival assay (Figure II-6B).
It has been reported that the asparagine synthetase (ASNS) gene is directly
regulated by ATF4 which binds its promoter (Gjymishka et al., 2009; Siu et al., 2002).
Indeed, we also found that ASNS expression was reduced by more than 70% in
shATF4 cells compared to shNT cells (Figure II-6C). Moreover, adding Asn to
HT1080.shATF4 cells rescued NEAA deprivation-induced G1 arrest (Figure II-3C), a
finding which is consistent with reports that ASNS deficiency can induce a G1 arrest
(Gong and Basilico, 1990; Greco et al., 1987). Furthermore, overexpression of ASNS
in shATF4 cells partially rescued cell survival (Figure II-6D). This result suggests that
ASNS is an important target for maintaining intracellular asparagine levels, which are
crucial for tumor cell survival and cell cycle progression.
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survival of shATF4 cells. (A) Survival of HT1080 (left) or DLD1 (right) cells grown

in DMEM with indicated amino acids supplemented at a concentration of 100μM for
48h. (B) Clonogenic survival of HT1080 shNT/shATF4 cells. Left: Picture of a
representative experiment. Right: Clonogenic survival of HT1080 shNT/shATF4 cells.
(Data represent mean ± SEM, n=4, *p< 0.05.) (C) ASNS mRNA levels in HT1080
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shNT/shATF4 cells measured using real time RT-PCR. (Data represent mean ± SEM,
n=3, *p<0.05.) (D) ASNS expression and cell survival in transfected HT1080 cells.
Left panel: top bands represent HA-tagged ASNS, lower bands represent endogenous
ASNS. Right panel: Survival of HT1080 shNT and shATF4 cells following indicated
treatments. After 24h, transfected cells were harvested for immunoblot or plated for
MTT assay (48h). (Data represent mean ± SEM, n=3, *p<0.05.)
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Knock-down of ATF4 increases sensitivity to glutamine deprivation

The amino acid glutamine serves not only as a substrate for nucleotide and
protein synthesis and as a precursor for the synthesis of Asn, but also as an important
energy source for tumor cells (DeBerardinis et al., 2007; Reitzer et al., 1979). To
produce Asn, ASNS transfers the amino group from Gln to Asp (Figure II-7A). Since
ASNS requires Gln to synthesize Asn, we wanted to test whether shATF4 cells were
more sensitive to Gln deprivation than shNT cells. To test this, shNT and shATF4
cells were cultured in DMEM with/without 2mM glutamine. MTT assays
demonstrated that shATF4 cells showed about a 50% reduction in survival in the
absence of Gln, while the shNT cells exhibited only a 25% reduction after 48h
incubation (Figure II-7B). Interestingly, adding Asn (100µM final concentration) to
Gln-deprived cells could partially rescue cell survival (Figure II-7C), suggesting that
producing Asn may also be an important role of Gln. In summary, ATF4 deficiency
severely inhibits tumor cell survival in vitro, which is primarily due to Asn
deprivation.
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ATF4 is necessary for tumor growth in vivo

The fact that ATF4 deficiency causes significant reduction in cell survival in
vitro suggests that ATF4 might play a role in tumor growth in vivo. To test this,

equal numbers of HT1080 shNT or shATF4 cells were injected in the flanks of nude
mice and tumor growth was monitored over a 3-4 week period. shNT cells grew
rapidly and formed large tumors. However, the shATF4 cells formed fewer tumors
that were also significantly growth-inhibited (Figure II-8A). Immunofluorecence
analysis of in vivo cell proliferation using the Ki67 antigen as a marker, demonstrated
that, consistent with the in vitro data, cells in shATF4 tumors had a significantly lower
proliferation rate (Figure II-8B), indicating that ATF4 promotes tumor cell
proliferation in vivo.
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Figure II-8: Knockdown of ATF4 blocks tumor growth in vivo.

(A) Left panel:

Photographs of xenografted tumors from HT1080 shNT/shATF4 cells in nude mice
injected in each side with 2 × 106 shNT or shATF4 cells. Tumors grew for 3 weeks.
Right panel: Average tumor weight at conclusion of experiment (Data represent mean
± SEM, n=10, *p<0.05.) (B) Left panel: Immunofluorescent staining for Ki67 (red)

in tumor sections. Nuclei were counterstained with Hoechst 33342 (blue). Tumors
were photographed at 200×magnification. Right panel: The quantification of Ki67
signal. (Data represent mean ± SEM, n=4, *p<0.05.)
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Discussion
Rapidly proliferating transformed cells have been shown to increase their
nutrient uptake in excess of their bioenergetic needs and to divert metabolic programs
towards pathways that support macromolecular biosynthesis to support their rapid
growth (DeBerardinis et al., 2008). Our study supports a model in which inhibition
of ATF4 leads to sub-optimal growth and survival of tumor cells and xenografts, due
to an imbalance between amino acid requirements and biosynthetic pathway function
and identifies asparagine as a key component of this regulatory mechanism.
Our previous studies showing higher sensitivity of ATF4-/- mouse embryonic
fibroblasts to hypoxia in vitro, coupled with reports of abnormal homeostasis of redox
balance and amino acid metabolism in these cells (Harding et al., 2003), prompted us
to investigate the relationship between the synthesis of ATF4 and stress conditions of
the tumor microenvironment, specifically nutrient deprivation and hypoxia.
Our studies show that inhibition of ATF4 in the absence of any additional
stress, sensitizes tumor cells to NEAA deprivation, a result that is consistent with
previous studies done in MEFs (Harding et al., 2003). In contrast to ATF4-/- MEFs,
which also required β-ME for survival, tumor cells expressing ATF4 shRNA did not
need antioxidant supplement to survive. This difference could be due to at least two
possible mechanisms: (a) the low level of ATF4 remaining in tumor cells still satisfies
the cellular needs for antioxidant activity; (b) tumor cells either overexpress
antioxidant enzymes or are more tolerant to oxidative stresses. However, ATF4
knockdown tumor cells did demonstrate reduced survival in the absence of NEAA,
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indicating that these cells were not able to synthesize certain amino acid(s) that is/are
crucial for survival and proliferation, thus cell cycle arrest, apoptosis and autophagy
were induced.
Autophagy is believed to enable cancer cells to survive under nutrient
starvation and has multiple roles in tumor progression. In this study, we found
evidence that loss of ATF4 leads to a lower apoptotic threshold; yet paradoxically also
appears to stimulate autophagy. However, this result can be explained under the prism
of energy homeostatic mechanisms: initially, loss of ATF4 (and thereby a substantial
portion of amino acid biosynthetic and transport capacity) leads to nutrient
deprivation and initiation of the autophagic response. This notion is supported by
morphological and molecular evidence demonstrating formation of double
membrane-engulfed cytoplasmic vacuoles and elevated levels of the autophagic
marker cleaved LC-3 in HT1080.shATF4 cells in the absence of NEAA. These
effects are readily but incompletely reversed when knockdown cells are supplemented
with NEAA, suggesting that amino acid deprivation is the key activator of autophagy.
Despite the activation of this pro-survival mechanism, however, the inability of
transformed cells to synthesize amino acids (and more specifically Asn) ultimately
leads to activation of apoptotic pathways culminating in cell death and loss of
clonogenic survival.
The pro-survival role of the initial autophagic response is further supported by
the fact that inhibition of Atg7, an enzyme responsible for fusion of peroxisomal and
vacuolar membranes, prevents the induction of autophagy and results in increased
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apoptosis in shATF4 cells. Interestingly, it has been recently reported that following
Bortezomib treatment, ATF4 promotes autophagy by upregulating LC3B levels and
this confers protection against Bortezomib-induced apoptosis (Milani et al., 2009).
In this work, we have shown that ATF4 deficiency leads to higher levels of processing
of LC3. Therefore, although ATF4 upregulation due to proteasomal inhibition can
positively affect autophagy, lack of ATF4 can also indirectly promote autophagy via
Asn depletion.
An analysis of the effect of individual amino acids on shATF4 tumor cells,
showed that supplementation of asparagine, and no other individual amino acid, was
sufficient to rescue cell survival, a finding that was later validated by our studies of
asparagine synthetase (ASNS). Among the known downstream targets of ATF4 are
proteins involved in amino acid transport and metabolism, including ASNS. HT1080
cells, like many other human tumor cell lines, grow in DMEM which is rich in
glutamine (4mM).

Glutamine deprivation significantly reduces survival of HT1080

and DLD-1 shATF4 cells, which could be partially rescued if asparagine was added.
This finding suggests that in tumor cells, the high requirement of glutamine (a vital
source of energy and nitrogen) (DeBerardinis et al., 2007; Sauer et al., 1982), may be
(at least partially) due to the biosynthesis of asparagine. According to our unpublished
microarray data, the expression of glutaminase, an enzyme that catalyzes glutamine
deamidation (the first reaction in glutamine catabolism), is upregulated by ATF4,
suggest that ATF4 may also promote tumor cells to make use of glutamine for energy
production.
41

Our in vivo experiment also established that ATF4 is necessary for tumor
growth. shATF4 cells formed fewer tumors which were significantly smaller and grew
slower compared to the rapid formation of large shNT tumors.

The shATF4 tumors

exhibited reduced proliferation rates based on analysis of Ki67 staining. More testing
need to be done to evaluate whether ATF4 deficiency leads to enhanced apoptosis rate.
Insufficient Asn supply may be the primary reason that shATF4 cell formed much
smaller tumors. At least two other aspects may also contribute to significantly reduced
tumor growth of shATF4 cells: (a) In addition to ASNS, ATF4 regulates other amino
acid metabolism-related genes. Unlike in vitro cell culture conditions, the tumor
microenvironment may lack other amino acids that can be synthesized in control
tumor cells but not in the shATF4 tumor cells; (b) ATF4 knockdown may inhibit
angiogenesis so that the shATF4 tumors could not obtain adequate nutrients from
blood.
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Chapter III: Activation of the cytoplasmic kinase GCN2 is
necessary for tumor cell survival, autophagy induction and
tumor growth under nutrient deprivation

This Chapter contributes to part of a manuscript submitted to EMBO J. (in revision)

Introduction
While ATF4 can be transcriptionally regulated (Siu et al., 2002), it is the
translational upregulation of ATF4 protein levels that has received the most attention.
It has been demonstrated that the ATF4 induction under ER stress depends largely on
PERK, while the induction under amino acid deprivation depends on GCN2 (Harding
et al., 2000; Lu et al., 2004; Vattem and Wek, 2004).
The role of PERK in tumor progression, hypoxic resistance and angiogenesis
has been reported. However, the regulation and potential contribution of GCN2 to
tumor progression has not been investigated yet. Considering that tumor cells highly
require nutrient supply such as glucose and glutamine, it is critical to investigate
whether GCN2 is critical for tumor cells survival under metabolic stresses such as low
amino acid and low glucose. In addition, based on our findings described in the
previous chapter, we hypothesized that asparagine shortage in ATF4 knockdown cells
may lead to GCN2 activation, which could regulate survival and proliferation.
In this study, we demonstrated that the activation of GCN2-ATF4 pathway
promotes tumor cell survival under nutrient (amino acid or glucose) deprivation.
Activation of GCN2 induces autophagy, which may contribute to cell survival under
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nutrient deprivation. GCN2-eIF2α pathway is activated in various human and mouse
tumor tissues. Deficiency of GCN2 severely inhibits tumor growth in vivo. Together,
these results suggest that GCN2-ATF4 pathway is a promising target for tumor
therapy.
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Results
Activation of the GCN2-eIF2α pathway under amino acid deprivation promotes
cell survival， upregulates p21 (cip1/waf1) and activates autophagy.

We hypothesized that if shATF4 cells are deficient in the biosynthesis of
non-essential amino acids, this should lead to activation of the upstream kinase GCN2,
completing an autoregulatory feedback loop.

Indeed, we found that GCN2 was

phosphorylated in HT1080.shATF4 cells and adding Asn or NEAA repressed this
phosphorylation (Figure III-1A), suggesting that knocking down ATF4 reduces ASNS
expression, causing an Asn deficiency which activated GCN2. eIF2α, the substrate of
GCN2, was also phosphorylated in shATF4 cells in response to NEAA and similar to
GCN2, its phosphorylation was repressed by addition of Asn or NEAA in trans. The
CDK inhibitors p21 and p27 play a critical role in G1/S cell cycle arrest in response to
stress, and it had been reported that they can be induced by amino acid deprivation
(Leung-Pineda et al., 2004). shATF4 cells constitutively expressed high levels of p21
compared to shNT cells. And the p21 expression were substantially reduced by adding
NEAA or Asn; however, p27 levels were unaffected (Figure III-1A). This is consistent
to a previous report that ATF4-null primary mouse bone marrow stromal cells have
increased p21 but not p27 expression (Zhang et al., 2008).
Since GCN2 is the molecular sensor of amino acid deprivation that induces
translational upregulation of ATF4, we tested whether GCN2 activation promotes
tumor cell survival when a single amino acid is removed from the culture media.
SV40-immortalized, Ras-transformed GCN2+/+ and GCN2-/- MEFs were cultured in
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DMEM with or without L-glutamine. Under Gln deprivation, GCN2+/+ cells showed
enhanced eIF2α phosphorylation and upregulation of ATF4, ASNS, and p21, while
the GCN2-/- cells failed to activate this pathway and had increased levels of
cleaved-caspase 3 (Figure III-1B). These results demonstrated that the induction of
p21 under amino acid starvation is dependent on GCN2 activation.
Since eIF2α is currently the sole known substrate of GCN2, we wanted to
further investigate whether the induction of ATF4 and p21 was dependent on eIF2α
phosphorylation. To test this, eIF2α wild-type or eIF2α S51A mutant MEFs (a
Ser-Ala mutation blocks eIF2α phosphorylation) were incubated in DMEM with or
without Gln. Similar to the GCN2-/- cells, eIF2α S51A mutant cells were unable to
induce ATF4, ASNS or p21 in the absence of Gln and had increased levels of
apoptosis (Figure III-1C).
In DMEM (+Gln, +Met), GCN2-/- cells showed 25% reduction in cell survival
compared to wild-type cells after 48h incubation, while Met or Gln deprivation
further reduced the cell survival of GCN2-/- cells to around 50% or 4%, respectively
(Figure III-1D).

In summary, the activation of GCN2-eIF2α−ATF4 pathway is

necessary for tumor cell survival under amino acid starvation.
It was previously reported that GCN2 activation and eIF2α phosphorylation
induce autophagy in yeast (Talloczy et al., 2002). We also observed a correlation
between GCN2 activation with LC-3 cleavage in HT1080.shATF4 cells (Figure
III-1A), suggesting that GCN2 could be the molecular switch that senses amino acid
shortage and induces autophagy in mammalian cells. To test this, wild-type, GCN2-/46

and eIF2α S51A mutant MEFs were incubated in Gln-free media. GCN2-/- cells had
significantly lower LC-3 processing compared to wild-type cells in response to Gln
starvation. eIF2α S51A mutant cells could not induce any LC-3 processing (Figure
III-1E). In conclusion, a functional GCN2-eIF2α pathway is required for amino acid
starvation-activated autophagy in transformed cells.
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Figure III-1. Activation of GCN2-eIF2α pathway under amino acid deprivation
promotes cell survival, upregulates ATF4 and p21, and activates autophagy.

(A)

HT1080 shNT and shATF4 cells were incubated in the media indicated for 24h.
Whole cell lysates were harvested for immunoblot (IB) or immunoprecipitation (IP)
with the indicated antibodies.

(B) GCN2+/+ and GCN2-/- MEFs were incubated

with/without 4mM Gln for 24h and immunoblotting was performed. (C) eIF2α wt or
eIF2α S51A mutant MEFs were incubated with/without 4mM Gln for 24h and
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immunoblotting was performed with indicated antibodies. (D) GCN2+/+ and GCN2-/MEFs were incubated with or without Met or Gln for 48h. Cell survival was analyzed
using MTT assay. (Data represent mean ± SEM, n = 3, *p < 0.05.) (E) Wild-type,
GCN2-/- and eIF2αS51A mutant MEFs were cultured without 4mM Gln for 1h or 3h,
cell lysates were subjected to immunoblotting.
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Generation of stable GCN2 knockdown cell lines

To study the role of GCN2 for tumor cells under nutrient deprivation, we
generated GCN2 knockdown cell line (HT1080.shGCN2) in the same manner as the
HT1080.shATF4 cell line. Three individual shGCN2 clones showed over 50%
reduction in GCN2 mRNA level (Figure III-2A). The reduced GCN2 expression was
confirmed by immunoblot (Figure II-2B). shGCN2 clone 12 had the lowest GCN2
expression, so it was chosen for further studies.
To further confirm that the GCN2 activity was inhibited in shGCN2 cells,
HT1080 shNT, shGCN2 and shATF4 cells were incubated in DMEM without
glutamine, ASNS expression was measured as readout for the GCN2-ATF4 pathway
activity.

Unlike shNT cells, ASNS expression could not be induced in shGCN2 or

shATF4 cells upon glutamine deprivation (Figure III-2C), suggesting that the ATF4
signaling, the GCN2 downstream target, is blocked in GCN2 knockdown cells.

50

A.
1.4

GCN2 expression

HT1080

*

1.2
1.0
0.8
0.6
0.4
0.2
0.0

cl5

cl3
sh
GC
N2

sh
NT
cl1

sh
NT
cl2

B.

sh
GC
N2
cl1
2

shNT cl2 shGCN2 cl3 shGCN2 cl5 shGCN2
cl12

sh
GC
N2

shNT cl1

GCN2

IP

MM

Ponceau

ASNS mRNA levels

C.

7% input

20
18
16
14
12
10
8
6
4
2
0

Gln(4mM)

H T1080

+

shN T

+

-

+

shGC N 2

-

shATF4

Figure III-2. Generating stable GCN2 knockdown cell line. (A) Real time RT-PCR

analysis for GCN2 mRNA levels in HT1080 clones expressing non-targeting shRNA
(shNT) or shRNA targeting human GCN2 (shGCN2). mRNA levels were normalized
against 18s rRNA internal control and are reported as a fraction compared to levels in
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shNT control cells. PCR reactions were done in triplicate. (Data represent mean ±
SEM,

n=3,

*p<0.05.)

(B)

GCN2

knockdown

was

confirmed

using

immunoprecipitation. Ponceau staining for 7% of input cell lysate was used as a
loading control. (C) HT1080 cells were incubated in full DMEM or DMEM (-Gln) for
8h. Total RNA was extracted for real-time PCR. Data represent mean ± SEM, n=3.
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Activation of phospho-eIF2α-ATF4 pathway under glucose deprivation depends
on GCN2.

Induction of ATF4-ASNS pathway by glucose deprivation has been observed
in tumor cell lines (Cui et al., 2007; Siu et al., 2002). The upstream event in ATF4
translational upregulation, eIF2α phosphorylation, can also be induced by glucose
starvation (Gomez et al., 2004), and it was suggested that this may be PERK
dependent (Gomez et al., 2008). In yeast, which do not express PERK, eIF2α
phosphorylation is dependent on GCN2 under glucose starvation (Yang et al., 2000).
Given that the carbon backbone of amino acids can enter glycolysis or the citric acid
cycle to produce ATP after deamination (Lehninger et al., 2008), and that GCN2 is
activated by uncharged tRNAs, we hypothesized that tumor cells may use amino acids
as alternative energy source under glucose deprivation. In this scenario, the reduced
amino acid pool should lead to GCN2 activation, eIF2α phosphorylation and
induction of ATF4 to increase amino acid synthesis/uptake.
To test this hypothesis, HT1080 cells were incubated in DMEM with/without
25mM glucose for 16h. GCN2 phosphorylation was detected after glucose deprivation,
and was associated with eIF2α phosphorylation (Figure III-3A). Moreover, adding
excess glutamine to the media potently suppressed eIF2α phosphorylation under
glucose deprivation (Figure III-3B), strongly suggesting that eIF2α phosphorylation
induced by glucose deprivation was due to a reduced intracellular amino acid pool. To
test whether the eIF2α phosphorylation in response to glucose deprivation was
dependent on GCN2, GCN2+/+ and GCN2-/- MEFs were glucose-deprived. Unlike
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wide-type cells, GCN2-/- MEFs could not phosphorylate eIF2α and induce ATF4 upon
glucose deprivation (Figure III-3C), suggesting that glucose withdrawal may activate
GCN2 to phosphorylate eIF2α and upregulate ATF4.
We wanted to test whether ATF4 target gene expression were induced under
glucose starvation. The mRNA levels of three downstream target genes of ATF4,
ASNS, SLC1A4 and SLC7A5 (two amino acid transporters) were significantly
increased by glucose deprivation in shNT cells, but not in shGCN2 or shATF4 cells
(Figure III-3D). Since several ATF4 target genes are involved in amino acid transport
and synthesis, it is likely that GCN2 senses the reduction of amino acid levels under
glucose deprivation and phosphorylates eIF2α to reduce global translation, but at the
same time upregulates ATF4 to supplement amino acid needs. We hypothesized that if
this was true, the activation of the GCN2-ATF4 pathway should protect cells under
glucose deprivation. Indeed, knocking down GCN2 or ATF4 sensitized tumor cells to
low glucose (Figure III-3E), indicating that the integrity of the GCN2-ATF4 pathway
is required for cell survival under glucose deprivation.
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Figure III-3: Glucose deprivation activates GCN2-eIF2α-ATF4 pathway. (A)

HT1080 cells were incubated with/without 25mM glucose for 16h. Whole cell lysates
(WL) were harvested for immunoblot (IB) or immunoprecipitation (IP). (B) HT1080
cells were incubated in glucose-free DMEM for up to 16h with indicated
concentrations of glutamine added and lysates were subjected to immunoblotting.
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(C) GCN2+/+ or GCN2-/- MEFs were incubated in glucose-free DMEM for up to 8h,

cells were harvested for immunoblot. Glutamine deprivation treatment was for 8h. (D)
HT1080 cells were incubated with/without 25mM glucose for 8h, total RNA was
extracted for real-time PCR. Data represent mean ± SEM, n=3. (E) HT1080 cells
were cultured with/without 25mM glucose, 2×104 cells/well. shATF4 cells were
supplemented with 1X NEAA. After 24h, cell survival was measured using MTT
assay and survival was normalized to that of the high glucose group. Data represent
mean ± SEM, n=3.
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Activation of GCN2 pathway contributes to tumor growth in vivo.

To test whether GCN2 is necessary for tumor growth in vivo, we performed
xenograft assay as previously using GCN2 proficient and deficient cells. First we
injected Ras transformed GCN2+/+ and GCN2-/- MEFs into nude mice and found that
GCN2-/- MEFs formed much smaller tumors compared to GCN2+/+ MEFs (Figure
III-4A). We also confirmed the necessity of GCN2 in tumor growth in human tumor
cell line HT1080. Similar to last experiment, knockdown of GCN2 in HT1080 cells,
completely blocked tumor growth in vivo (Figure III-4B), suggesting that in vivo
tumor growth require the integrity of GCN2-ATF4 pathway.
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Figure III-4: Inhibition of GCN2 pathway blocks tumor growth in vivo. (A)

Growth of K-RasV12-transformed GCN2+/+ and GCN2-/- MEFs in vivo. Nu/Nu mice
were injected in each side with 2.5 × 106 MEFs. Tumors grew for 9 days. At the end
of the experiment, tumors were excised, photographed (left) and weighed (right).
(Data represent mean ± SEM, N=4, *p<0.05, Paired two-tailed Student's t-test). (B)
Growth of HT1080.shNT and HT1080.shGCN2 tumor xenografts. Nu/Nu mice were
injected in each side with 2 × 106 shNT (N=7) or shGCN2 cells (N=10). 6 days after
injection, tumor volume was measured every 2-3 days. Data represent mean ± SEM.
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Upregulation of GCN2 signaling in tumor tissues

To investigate whether the GCN2-eIF2α pathway is activated in primary
tumors, clinical samples of human liver, breast and lung tumors with corresponding
normal tissue controls were homogenized and lysates subjected to immunoblotting.
Three out of four liver tumors and the samples from breast and lung tumors exhibited
substantial GCN2 overexpression and increased phospho-eIF2α levels compared to
normal tissues (Figure III-5A). Similar results were obtained from spontaneous mouse
tumors. For this, we analyzed the GCN2 pathway in tumors and corresponding
histologically normal breast tissue from mammary tumor-prone MMTV-Neu mice.
We found that all mouse breast tumors exhibited significantly higher levels of GCN2,
as well as increased levels of eIF2α phosphorylation compared to surrounding normal
tissue from the same mice (Figure III-5B).
Despite extensive efforts, we could not detect phospho-GCN2 in tissue
homogenates by immunoblot, even after GCN2 immunoprecipitation, probably due to
loss of the phospho-group during tissue homogenization or immunoprecipitation.
Therefore, we performed immunohistochemical staining for total and phospho-GCN2
levels using paraffin-embedded human tumor tissue microarrays. Colon and breast
carcinoma tissues exhibited very strong staining of total and phospho-GCN2; Less but
substantial staining of total and phospho-GCN2 were detected in ovarian and lung
carcinoma; In contrast, normal tissues showed very little or no staining for total or
phospho-GCN2 (Figure III-6).

Interestingly, phospho-GCN2 staining was not

homogeneous across the tumor section, suggesting that local microenvironmental
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factors might be affecting its phosphorylation.

In summary, the upregulation of

GCN2-eIF2α-ATF4 signaling module in tumor compared to normal tissues implies
that tumor cells there must exist a tumor-specific requirement for GCN2 activation in
tumors for adaptation to a nutrient-deprived microenvironment.
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Figure III-5: The GCN2/p-eIF2α pathway is activated in human and mouse
spontaneous tumors. (A) Immunoblots for GCN2 and p-eIF2α in human tumor
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Discussion
The GCN2-eIF2α-ATF4 signaling module has been described as a vital
regulator of protein synthesis and amino acid metabolism in response to amino acid
deprivation in eukaryotes, from yeast to mammals (Sood et al., 2000). Yet, the
consequences of ablating components of this pathway on survival and proliferation of
transformed cells under physiological and stress conditions in vitro and in vivo have
not been adequately described. Our studies have provided evidences that GCN2
activation contributes to tumor cell survival under nutrient deprivation due to eIF2α
phosphorylation, upregulation of ATF4 and induction of autophagy.
GCN2, a protein kinase activated by uncharged tRNAs that occur under amino
acid deprivation, triggers the repression of protein synthesis as well as the
upregulation of amino acid biosynthesis/transportation via increased translation of
ATF4 mRNA. Both GCN2 and its substrate eIF2α, showed increased phosphorylation
in shATF4 cells, and the phosphorylation was reduced when cells were treated with
Asn or NEAA. Under glutamine deprivation, GCN2+/+ cells exhibited increased
eIF2α phosphorylation, and ATF4, ASNS, and p21 induction; in contrast, GCN2-/cells were not able to activate this pathway and underwent apoptosis. Moreover, the
induction of ATF4 and p21 under amino acid deprivation depends on eIF2α
phosphorylation,

suggesting

that

p21

may

be

translationally

induced

by

phosphorylated eIF2α. Under genotoxic stress, the induction of p21 contributes to cell
survival by blocking cell cycle progression and allowing sufficient time for the repair
of damaged DNA (McDonald et al., 1996). Although it remains to be formally
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demonstrated, the induction of p21 under amino acid starvation is likely responsible
for the G1/S cell cycle arrest in shATF4 cells and it may similarly play a
cytoprotective role, by inhibiting proliferation and thus promoting conservation of
energy otherwise expended for protein synthesis. However, additional experiments are
required to confirm this. We propose to use siRNA to knock down p21 and check
whether it releases shATF4 cells from G1 phase arrest and whether it further increase
cell death.
Our finding that eIF2α phosphorylation and ATF4 induction under low
glucose is GCN2-dependent also demonstrates that GCN2 is a molecular switch that
senses nutrient deprivation in the tumor microenvironment. Our data suggest that
glucose metabolism and amino acid metabolism are strongly connected. Under
glucose starvation, tumor cells activate GCN2-ATF4 pathway to increase amino acid
uptake, which compensates for glucose shortage. GCN2 activation can downregulate
protein synthesis (eIF2α phosphorylation), slow down cell cycle progression (p21
induction), and increase amino acid uptake (ATF4 induction). These responses could
help tumor cells conserve energy and maintain nutrient homeostasis (Figure III-8).
Another pro-survival function of GCN2-eIF2α pathway under amino acid
deprivation may be the induction of autophagy. Consistent to previous study done in
yeast (Talloczy et al., 2002), phosphorylation of eIF2α is required for autophagy
induction in MEFs, though further investigation is needed to determine the
mechanism. The LC-3II levels in GCN2-/- cells are lower compared to wide-type cells,
but higher than those in eIF2α mutant cells. This may due to the crosstalk from other
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eIF2α kinases (PERK, PKR, etc.)
Several of these in vitro findings were recapitulated in vivo by comparing
tumor growth in GCN2 knockdown or knockout cells with their WT counterparts.
Similar to shATF4 tumor cells, HT1080.shGCN2 cells or Ras-transformed GCN2
knockout MEFs were unable to form large tumors in vivo. The slower tumor growth
in ATF4 and GCN2-deficient cells reflects the tumor cells’ dependency on the
integrity of GCN2-eIF2α-ATF4 pathway under nutrient deprivation; this reliance for
tumor cell growth makes the GCN2-eIF2α-ATF4 pathway a biological target for
anti-tumor approaches. It is important to note that GCN2-/- mice do not exhibit gross
morphological or functional abnormalities unless they are fed a diet lacking certain
essential amino acids, such as Leucine (Anthony et al., 2004). Since ATF4-/- mice
exhibit abnormalities such as micropthalmia and anemia, (mostly attributed to the
antioxidant role of ATF4), GCN2 might offer a better therapeutic target than ATF4.
We would predict that normal tissues with sufficient nutrient supply would not be as
affected by a specific GCN2 inhibitor compared to tumor tissues which would be
under nutrient deprivation (due to suboptimal blood flow and increased metabolic
demands) and thereby be more dependent on functional GCN2 for survival and
proliferation.
The fact that GCN2 was highly overexpressed in multiple tumor tissue
suggests that GCN2 plays an important role in tumor progression. Further
experiments need to be done to determine whether high GCN2 expression facilitates
transformation or whether it is just an adaptive effect of transformation. Since
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phospho-GCN2 can be detected by immunohistochemistry in tumor sessions, it could
be utilized as a molecular marker for detecting nutrient starvation stress in tumor
tissues.
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Chapter IV: ATF4 contributes to the hypoxic resistance of
tumor cells and selectively regulates gene expression under
hypoxia
Introduction
In the tumor microenvironment, the abnormal development of vasculature
results in insufficient blood supply, which is the major reason for the development of
acute and chronic hypoxia. Hypoxia activates HIF-dependent and HIF-independent
pathways. One of the HIF-independent pathways activated by hypoxia is the
PERK-eIF2α-ATF4 pathway. Previously, we demonstrated that PERK activation and
the resulting eIF2α phosphorylation increase the ability of transformed cells to
survive hypoxia in vitro and in vivo and promote tumor growth (Bi et al., 2005). In the
same study, we reported that as a downstream target of PERK and
phospho-eIF2α, ATF4 also contributes to hypoxia resistance in MEFs. We and others
reported that ATF4 overexpression is elevated in primary tumor tissues and
co-localizes with hypoxic regions (Ameri et al., 2004; Bi et al., 2005). However,
several key questions remained unanswered: Is ATF4 necessary for tumor cell
survival under hypoxia? What are the genes activated under hypoxia?
In this study, we demonstrate that ATF4 contributes to tumor resistance to
hypoxic stress. Despite ATF4 upregulation under hypoxia, ASNS expression was
repressed, suggesting that ATF4 selectively activates expression of specific genes
under hypoxia.
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Results
ATF4 protects tumor cells from hypoxic stress

We previously reported that ATF4 is induced by hypoxia through PERK
activation and ATF4 overexpression in primary tumor secessions (Bi et al., 2005). To
test whether the ATF4 induction under hypoxia has a protecting effect in tumor cells,
survival of shNT and shATF4 cells was measured after exposure to normoxia or
severe hypoxia (0.2% O2). As shown in figure IV-1A, the shATF4 cells showed
increased cell death after hypoxia treatment compared to corresponding shNT cells.
Immunobloting confirmed that ATF4 protein was induced in shNT cells but not in
shATF4 cells under hypoxia (Figure IV-1B). Moreover, when mouse ATF4 was
overexpressed in these cells, the rescue effect of ATF4 re-expression was more
pronounced under hypoxia (Figure IV-1C), suggesting that ATF4 may have additional
roles for maintaining cell survival under hypoxia.
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Figure IV-1. ATF4 promotes cellular resistance to hypoxia. (A) Cell survival

(assayed by MTT assay) of HT1080 cells exposed to normoxia (21% O2) or hypoxia
(0.2 % O2). Experiment was performed in triplicate and error bars indicate S.E. (B)
Immunoblot of ATF4 levels from nuclear fractions of the normoxia/hypoxia (0.2% O2)
treated (24h) cells. (C) HT1080 shATF4 cells were infected with an Adeno-mATF4
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virus or an Adeno-cre virus. Infected cells were plated in 24 well plates for MTT
assay as before. Hypoxia treatment was same as before. Experiment was performed in
triplicate and error bars indicate S.E. *p<0.05.
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ASNS expression is repressed under hypoxia

It has been reported that some ATF4 target genes (ATF3, TRB3, CHOP, etc.) are
transcriptionally upregulated under low oxygen, but there is not much information
about how the other ATF4 target genes, especially the amino acid metabolism related
genes, are regulated by hypoxia. To study this, we measured ASNS mRNA levels in
HT1800 shNT and shATF4 cells under normoxic and hypoxic conditions. It was
intriguing that even though ATF3 expression had a 4-fold induction under hypoxia in
shNT cells indicating an increase in ATF4 activity, ASNS expression was decreased
by about 50% under hypoxia. In addition, knockdown of ATF4 only inhibited hypoxic
induction of ATF3, but did not affect it under normoxia, while ASNS expression was
strongly repressed in shATF4 cells, under both normoxic and hypoxic conditions
(Figure IV-2A).
To understand how ATF4 regulates gene expression under low oxygen,
especially the enzymes and transporters involved in amino acid metabolism, HeLa
cells were transfected with siRNA against ATF4, exposed to hypoxia, and a
microarray analysis was performed. Though ATF4 protein levels increased
significantly upon hypoxia (Figure IV-2B), the mRNA levels of ASNS and SLC7A11
(an amino acid transporter) were repressed (Figure IV-2C), suggesting that even
though ATF4 is translationally upregulated under hypoxic stress, the expression of
ATF4 targets ASNS and SLC7A11 was repressed.
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Figure IV-2. ATF4 selectively regulates gene expression under hypoxia. (A) Real

time RT-PCR analysis for ATF3 and ASNS mRNA levels in HT1080 cells. Hypoxia:
0.2% O2, 24 hours. mRNA levels were normalized against 18s rRNA internal control
and are reported as a fraction compared to levels in normoxic shNT control. (B) ATF4
protein levels from the nuclear fractions of HeLa cells. Hypoxia: 0.2% O2, 8 hours.
Lamin was used as a loading control. (C) Microarray analysis for RNA collected from
samples treated in the same way as in B.
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Discussion
Hypoxia in the tumor microenvironment has been previously shown to induce
ATF4 through PERK activation (Ameri et al., 2004; Blais et al., 2004). Our data
demonstrated that ATF4 knockdown further sensitize tumor cells under hypoxia,
indicating that the expression of ATF4 has a significant role in protecting tumor cells
from oxygen deprivation and promoting cell survival under hypoxic treatment.
Surprisingly, based on real-time and preliminary microarray experiments, we
have found that although the induction of hypoxia causes robust upregulation of ATF4,
not all ATF4 transcriptional targets are induced by hypoxia, while some of the ATF4
targets, including ASNS and SLA7A11, are even repressed by hypoxia. We believe
that under conditions of low oxygen availability ATF4 may undergo post-translational
modifications or interact with different partners to selectively regulate gene
expression. It will be necessary to perform chromatin immunoprecipitation (ChIP)
assay to test whether the ATF4 binding efficiency to ASNS promoter is reduced under
hypoxia or perform immunoprecipitation assay to test whether the ATF4 binding
efficiency to other transcriptional cofactors is reduced under hypoxia.
In summary, ATF4 is an important transcription factor activated upon hypoxic
stresses.

Since the ATF4-dependent gene expression profiles are different upon

different stress conditions, the role of ATF4 in tumorigenesis and tumor
chemoresistance appears to be a complicated one and may depend upon the stress
(hypoxia, amino acid deprivation, oxidative stress, etc.) which induces it. Animal
models in which ATF4-/- or ATF4 conditional knockout mice are crossed to existing
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tumor models will be required to elucidate its precise role in tumor progression.
Nevertheless, the evidence so far points toward a pro-tumorigenic role for this protein
when expressed under hypoxia and therefore suggests it may be a good target for
anti-tumor therapies.
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Chapter V: General Discussion

The role of ATF4 in regulating amino acid metabolism in tumor cells

Our work illustrates that ATF4 is necessary for tumor cells to produce enough
asparagine, which is critical for tumor cell survival and proliferation. The dominant
effect of asparagine requirement in vitro were discovered in HT1080 and DLD1 cells
since both cell lines were cultured in DMEM, which does not contain exogenous
asparagine. It is reasonable to imagine that if McCoy’s 5A had been used for growing
these cells, we would not have discovered the importance of asparagine since
McCoy’s 5A has asparagine. Culturing in DMEM is a selective pressure that selects
cells with sufficient ASNS expression. Based on our microarray data, dozens of
ATF4-dependent genes are amino acid transporters, aminoacyl tRNA synthetases, or
enzymes involved in amino acid metabolism. It is possible to identify additional ATF4
target genes that contribute to tumor progression under different selection pressures.
For instance, our preliminary data showed that cysteinyl-tRNA synthetase (CARS)
expression is reduced about 50% in ATF4 knockdown cells, and ATF4 knockdown
cells are more sensitive to cysteine deprivation. More detailed work needs to be
carried out to reveal the entire potential of ATF4 in regulating tumor metabolism. In
vivo, shATF4 cells suffered a more severe growth deficiency compared to in vitro

growth. This suggests that there may be a combination of multiple selection pressures,
since the poor tumor microenvironment does not supply as much nutrients, growth
factors and oxygen as culture medium does in vitro.
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Although ATF4 is considered an anti-stress protein, some ATF4 targets directly
promote cell death (e.g., CHOP). Overexpression of ATF4 may also be toxic to cells
(Ord et al., 2007), though in these experiments, exogenous ATF4 levels were elevated
well-beyond physiological levels using tet-inducible systems. It is likely that mild to
moderate ATF4 induction protects cells from stress, but prolonged or acute induction
of ATF4 may induce cell death due to CHOP overexpression or another yet
unidentified mechanism.

The role of ASNS in response to amino acid deprivation and ATF4
downregulation

Our data showed that tumor cells require asparagine to survive and proliferate.
However, further investigation is still needed into the precise role of Asn in tumor cell
survival and tumor growth. It is unclear if Asn is just a substrate for protein synthesis,
or whether it has additional, yet unidentified functions in tumor cell metabolism and
proliferation.
Interestingly, L-asparaginase, an enzyme that catalyzes the biodegradation of
asparagine, is a common chemotherapeutic agent of childhood acute lymphoblastic
leukemia (ALL) and forms of acute myeloblastic leukemia (AML) (Cooney and
Handschumacher, 1970; Ertel et al., 1979; Richards and Kilberg, 2006). To
compensate for the lack of exogenous asparagine available to L-asparaginase treated
cells, leukemic and even stromal cells upregulate ASNS synthesis and activity, which
may contribute to the development of L-asparaginase resistance during treatment of
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ALL (Aslanian et al., 2001; Hutson et al., 1997). Moreover, a causal relationship
between L-asparaginase activity and ASNS expression has been observed in several
ovarian cancer cell lines (Lorenzi et al., 2008). The ability of ASNS expression to
rescue (at least partially) survival and growth of cells with reduced ATF4 levels,
coupled with the clinical efficacy of L-asparaginase in ALL, highlight the importance
of this pathway in the maintenance of amino acid homeostasis. Our study also
supports the need for further screening of cancer cells lines and strains which might
be highly sensitive to L-asparaginase treatment and to balance the administration of
L-asparaginase with the potential development of drug resistance. It is also interesting
to test whether the ASNS upregulation in L-asparaginase resistance cells is ATF4
dependent, and whether inhibition of ATF4 re-sensitizes the resistance tumor cells.

GCN2 governs amino acid metabolism in tumors and is necessary of tumor
growth

Our in vitro and in vivo experiments demonstrated that GCN2 has a dominant
role for tumor cell survival under nutrient deprivation. The fact that GCN2 is
activated under glucose starvation further validated that glucose metabolism and
amino acid metabolism are tightly connected; tumor cells switch to amino acids as
energy source in the absence of glucose. Consistent with previous findings, glutamine
is used for energy production in the absence of glucose. Further studies are required to
discover what other amino acids may be involved in this ‘salvage’ process.
The relationship of GCN2 activation and autophagy induction was first
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discovered in yeast (Talloczy et al., 2002). Our finding confirmed that in mammalian
cells, autophagy induction also depends on GCN2 activation and eIF2α
phosphorylation. There are two known consequences of eIF2α phosphorylation:
Inhibition of translation initiation and translational upregulation of specific genes
which have 5’UTR structures similar to ATF4. Therefore we hypothesize that
autophagy could be induced in two ways by phospho-eIF2α: Downregulating
autophagy inhibitors by inhibition of their translation and/or translational upregulation
of autophagy stimulators. There must be other unidentified phospho-eIF2α targets
that activates autophagic pathway. Since mTOR activition requires the presence of
amino acids, and inhibition of mTOR by rapamycin leads to autophagy activation, it
will be motivating to study whether GCN2 negatively regulates mTOR activity upon
amino acid starvation.
The fact that p21 induction under amino acid deprivation depends on GCN2
and phospho-eIF2α implied that p21 may be translational regulated in the same way
as ATF4. To find out whether p21 mRNA has uORFs in 5’UTR, we searched the two
p21 transcript variants. We found that in transcript variant 2, there does exist an uORF
in 5’UTR partially overlapped with the p21 ORF (Figure V-1). Since there is one
nucleotide shift between this uORF and the actual p21 ORF, translation of this uORF
will produce a short peptide and inhibit p21 translation. This suggests that p21 could
be translationally upregulated under stressed conditions, when eIF2α phosphorylation
blocks the translation initiation at the uORF. Interestingly, the p21 transcript variant
1 does not have such structure. It will be important to investigate whether p21
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mRNA undergo alternative splicing upon stresses.
Although we showed that knockdown of GCN2 inhibits tumor xenograft
growth, suggesting that GCN2 has critical functions for solid tumor growth, it is
difficult to address whether GCN2 is important for tumor initiation and/or progression
in a xenograft tumor model. In the future, we plan to cross GCN2 wild-type or
knockout mice to an endogenous pancreatic cancer model to explore this issue. The
fact that GCN2 is highly overexpressed in tumor tissues suggests that GCN2 may be
necessary for malignant growth. It will be interesting to test whether GCN2 mRNA
increases in tumor tissues, and if this is the case, whether there are binding sites for
oncogenic transcription factors in GCN2 promoter.
Since no potent and specific GCN2 inhibitor has been reported yet, it is urgent
to do large-scale drug screen in small molecular libraries. Tumor cells expressing
ATF4-Luc construct can be starved with one or several kinds of amino acids, and the
drugs inhibiting luciferase activities will be selected for further investigation. It will
be important to test whether GCN2 inhibitors and L-asparaginase have synergic effect
on ALL and AML cancer patients.
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Homo sapiens cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A),
transcript variant 2, mRNA (part, 1-780nt)

5’

3’
5’uORF

p21

Figure V-1. The structure of p21 mRNA (transcript variant 2).

Upper panel: p21 mRNA sequence (1-780). 5’uORF is labeled as red. The p21
translation start and stop codes are labeled as yellow.
Bottom panel: A representative figure demonstrating p21 mRNA structure.
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The role of ATF4 in tumor resistance to hypoxia

Although our data clearly demonstrated that ATF4 contributes to tumor
resistance to hypoxia, an important issue was not addressed: what ATF4 targets are
involved? It was very surprising that, despite the upregulation of ATF4 by hypoxia,
the expression of two ATF4 targets, ASNS and SLC7A11 were strongly
downregulated. Our preliminary data suggests that under hypoxia, the expression of
some HIF targets such as Glut1 and CA9 are increased in ATF4 knockdown cells
(data not shown), implying a competition between HIF and ATF4. It is possible that
HIFs have higher affinity for binding to transcription cofactors than ATF4, thus
reducing ATF4 activity on the promoters of some of the ATF4 targets. This hypothesis
could be tested by measuring ASNS expression in HIF-null cells. The fact that some
ATF4 targets including ATF3, CHOP and TRB3 are still induced under hypoxia
suggests that ATF4 selectively regulates gene expression under hypoxia. It will be
interesting to compare the promoter structures of hypoxia induced/repressed genes to
identify whether the two groups of promoters have different constitutions of ATF4
binding elements. Previous reports suggest many HIF targets play important roles in
tumor glucose metabolism under hypoxia, increasing glucose uptake (Glut1),
attenuating mitochondrial respiration and promoting anaerobic glycolysis (PDK1,
LDHA, etc.) (Dang, 2007; Semenza, 2009). We still do not know much about how
hypoxia regulates amino acid metabolism. The fact that hypoxia inhibits ASNS and
SLA7A11 expression suggests that cells may tend to downregulate amino acid uptake
and synthesis under hypoxia.
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Chapter VI:

Materials and methods

Cell culture and generation of the stable cell lines

HeLa, HT1080 and DLD1 cells were cultured in DMEM (4.5g/L glucose, 4mM
glutamine) supplemented with penicillin, streptomycin, 10% fetal calf serum. To
establish stable ATF4 knockdown cell lines, HT1080 and DLD1 cells were transfected
with

pLKO-shNT

or

pSM2-shATF4

plasmids

(OpenBiosystems)

using

Lipofectamine2000 (Invitrogen) and selected with Puromycin (2µg/ml and reduced to
0.5µg/ml for maintenance). All cells were supplemented with non-essential amino
acids (NEAA) and 55µM β-mercaptoethanol (β-ME) after transfection. Stable GCN2
knockdown cell line was produced in the same manner. All the MEFs were cultured in
the same conditions as HT1080.shATF4 cells. Individual amino acids (Sigma) were
dissolved in water to make 10mM (100X) stock solutions.

Real-time PCR

RNA was isolated from cells following TRI-Reagent protocol (Invitrogen). Reverse
transcription was performed using AMV Reverse Transcriptase (Promega). Real time
PCR was done on Applied Biosystems 7300 Real-Time PCR System using Power
SYBR® Green PCR Master Mix.
Primer sequences:
ATF4: 5’-TCCCATCTCCAGGTGTTCTC-3’ (forward),
5’-CAGCTCTTTGCACTCACCAG-3’ (reverse).
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ASNS: 5'-TACAACCACAAGGCGCTACA-3' (forward),
5'-AAGGGCCTGACTCCATAGGT-3' (reverse).
SLC1A4: 5’-AGCTCAAC GCAGGACAGATT-3’(forward),
5’-ATTCAGGTGGTGGAGAATGC-3’(reverse).
SLC7A5: 5’-GGAGGCTGCTGTGAAAACTC-3’ (forward),
5’-AGGAGAAAGGA AGGCTCCTG-3’ (reverse).
GCN2: 5’-TGCCAACTTACATCAGAAAAGC-3’ (forward),
5’-TTTGAGGTATATTTGCTTTGG-3’ (reverse).
ATF3: 5’-TAGGCTGGAAGAGCCAAAGA-3’ (forward),
5’ TTCTCACAGCTGCAAACACC-3’

Cell survival, proliferation and apoptosis assays

MTT assay was performed using Cell Proliferation Kit I (Roche Diagnostics). Cell
proliferation was assayed with Click-iTTM EdU Flow Cytometry Kit (Invitrogen).
Caspase 3/7 activities were measured using Caspase-Glo 3/7 Kit (Promega). For
clonogenic survival assays, cells were plated at a density of 500 cells per plate,
incubated for 12 days and fixed with 10% methanol/10% acetic acid and stained with
0.4% crystal violet. Since HT1080 cells do not form well-defined colonies, 300µl
33% acetic acid was added to each dish to solubilize the stain which was transferred
to a 96 well plate and absorbance was read at 540nm. The average normalized
surviving fraction from four independent experiments and the S.E. are reported.
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Plasmids and viral vector

siRNA against ATF4 and ATG7 were purchased from Dharmacon. pCMV-mATF4
vector and Adeno-mATF4 virus was a gift from Dr. Guozhi Xiao (Department of
Medicine, University of Pittsburgh). pCMV-HA-ASNS vector was purchased from
OriGene. ATF4 and GCN2 shRNA vectors are from Open Biosystems.

Immunofluorescence

Fresh-frozen tumors were sectioned (10 μ m) and fixed to glass slides in 4%
formaldehyde for 30 min. Sections were then blocked in 3% BSA in PBS for one hour.
For detection of proliferation a Ki-67 antibody (sc-15402, Santa Cruz Biotechnology
Inc.) was used at dilution 1:50, followed by Cy3-conjugated secondary (ZyMax Goat
Anti-Rabbit IgG from Invitrogen). Fluorescence immunostaining was detected using
Nikon eclipse TE2000-U microscope and photographed at several magnifications.
Experiments were performed in triplicate. Images of three different areas of each
tumor section were captured and the quantitation of proliferating cells was determined
using Matlab software.

Immunoblotting

Immunoblotting was performed as described previously (Koumenis et al., 2002). The
antibodies used were: anti-ATF4 (Santa Cruz Biotechnology), anti-β-actin and
anti-α-tubulin (Sigma-Aldrich), anti-p-eIF2α, anti-eIF2α, anti-p-GCN2, anti-GCN2,
anti-cleaved caspase-3, anti-cleaved PARP, anti-LC3II (Cell Signaling Technology
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Inc.), anti-p21 (BD Pharmingen ™ ), anti-p27 (BD Transduction Laboratories ™ ),
anti-ASNS (Abcam).

Animals

Athymic NCR-Nu/Nu male mice of ages 6–8 wk (NCI at Frederick) were used.
Animals were housed and cared for at the University of Pennsylvania, Stemmler
Animal facility. All animal experiments were performed in accordance with NIH
guidelines and with the approval of the University of Pennsylvania Animal Use
Committees (IACUC). Nu/Nu mice were subcutaneously injected with HT1080 cells
(2 × 106 cells/tumor)or MEFs (2.5 × 106 cells/tumor). When tumors became
cumbersome or necrotic (approx. 3 weeks for HT1080 or 9 days for MEFs), mice
were sacrificed; tumors were excised, photographed, weighed, frozen and embedded
in OCT freezing medium.

Tumor samples and Immunohistochemistry for GCN2.

Snap frozen, human tumor and normal tissues (liver, breast and lung) were obtained
from the Tumor Tissue and Biospecimen Bank (TTAB) Facility at the University of
Pennsylvania, School of Medicine. Collection and processing of human specimens
was performed in accordance to regulations of the Abramson Cancer Center and the
Department of Pathology and Laboratory Medicine at the University Of Pennsylvania
School Of Medicine. The mouse breast tumors arose from MMTV-Neu transgenic
mice. Unaffected normal mammary glands were simultaneously harvested from the
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same animal. Tissues were immediately frozen on dry ice and stored at -80oC. All the
tissues were homogenized in lysis buffer using a ULTRA-TURRAX homogenizer
(Janke&Kunkel).
Multitumor tissue microarray slides (T-MTA-6A) were obtained trough the Tissue
Array

Research

Program

(TARP,

NCI-Frederick).

Formalin-fixed,

paraffin-embedded tissue slides were deparafinized and rehydrated in distilled water
followed by antigen retrieval using 10 mM sodium citrate (buffer pH 6.0) and
endogenous peroxidase inactivation with 3% hydrogen peroxide.

Sections were

blocked with 5% normal goat serum and incubated in Rabbit polyclonal
anti-Phospho-GCN2 antibody (1:50, Cell Signaling Technologies) and goat anti-rabbit
Horseradish Peroxidase secondary antibody (1:200, Sigma-Aldrich).
detection we utilized DAB chromogen.

For antigen

Slides were counterstained in Mayer's

hematoxylin, mounted and photographed using a Nikon microscope. All tissues were
procured according to University of Pennsylvania IRB guidelines.

Cell Cycle Analysis

HT1080 cells were cultured in regular DMEM, DMEM with 100µM Asn or DMEM
with 100µM NEAA for 24hs. Cell cycle analysis was performed as previously
described (Javvadi et al., 2008).

Hypoxia treatments

Cells were placed in an InVivo2 400 hypoxia workstation (Biotrace, Inc) for the time
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and oxygen concentration indicated

Statistics

All statistics were performed using unpaired two tailed student's t test unless
otherwise specified. A p value of 0.05 was chosen as the threshold for statistical
significance. If the p value is smaller than 0.05, the means of two groups are
significantly different.
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